期刊文献+

基于叶酸受体的靶向性钆造影剂的制备及弛豫性能的研究 被引量:3

Preparation of Targeted Gd^(3+) Contrast Agent Based on Folate-receptor and Its Relaxation
下载PDF
导出
摘要 目的制备基于叶酸受体的靶向大分子磁共振造影剂——叶酸-壳聚糖-(Gd-DTPA)n,并研究其体外弛豫性能。方法在EDC的催化下,将壳聚糖与DTPA反应,制得壳聚糖-DTPA偶联物,然后将该偶联物与叶酸活性酯反应所得产物与GdCl3螯合得到叶酸-壳聚糖-(Gd-DTPA)n。在磁共振仪上测定配合物的体外弛豫时间T1,并分析其弛豫性能R1。结果制得的叶酸-壳聚糖-(Gd-DTPA)n配合物中叶酸的偶联率约为4,Gd-DTPA与壳聚糖的偶联率随着EDC的加入量增大而增大,体外弛豫性能R1约为6.2×10-3L.mmol-1.ms-1,比小分子Gd-DTPA的弛豫性能提高了2.3倍左右。结论成功地制备了叶酸介导的高弛豫效能的靶向性磁共振造影剂。 OBJECTIVE To prepare the complexes of folate-chitosan-( Gd-DTPA )n a novel kind of folate-receptor-targeted macromolecular MRI contrast agents,and to evaluate their relaxation in vitro. METHODS Catalyzed by EDC at pH 〉 6. 5, chitosan was reacted with DTPA to form chitosan-DTPA, then the complexes of chitosan-chitosan-( Gd-DTPA ), were obtained by chelating of GdC13with the product of folate-DTPA coupled with activated folate ester at pH 7 - 8. The in vitro spin-lattice relaxation of these Gd complexes were preliminarily investigated. RESULTS The coupling ratio of folate to chitosan was about 4, and the ratio of Gd-DTPA to chitosan was increased with the increasing of EDC. The relaxation of these complexes was about 6. 2 × 10^-3L · mmol^-1 · ms-1, that' s about 2. 3 times as the small molecular Gd-DTPA complex. CONCLUSION The MRI contrast agents mediated by folate had been prepared successfully and had high relaxation.
出处 《中国药学杂志》 CAS CSCD 北大核心 2007年第21期1640-1644,共5页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(30300430) 湖北省自然基金资助项目(2006ABA123)
关键词 叶酸 肿瘤靶向 钆造影剂 壳聚糖 体外弛豫性能 folate cancer-targetmg Gcl contrast agent chitosan relaxivity in vitro
  • 相关文献

参考文献6

二级参考文献43

  • 1俞开潮,王国平,丁尚武,叶朝辉.用于磁共振成像对比增强的造影剂研发进展[J].波谱学杂志,2004,21(4):505-525. 被引量:18
  • 2周锦兰,万福贤,俞开潮,丁尚武.两亲性双核钆(Ⅲ)配合物的合成与肝选择MRI增强[J].高等学校化学学报,2005,26(8):1391-1394. 被引量:3
  • 3俞开潮,卓仁禧.两亲性聚酯配体及其钆(Ⅲ)配合物的合成和弛豫性能研究[J].离子交换与吸附,1996,12(3):238-244. 被引量:4
  • 4Curtet C, Bourgoin C, Bohy J, et al. Gd-25DTPA-Mab, a potentialNMR contrast agent for MRI in the xenografted nude mouse:preliminary studies. Int J Cancer Suppl,1988,2 : 126-132.
  • 5Curtet C, Manton F, Havet T,polylysine-Gd-DOTAn coupled toet al. Polysine-Gd-DTPAn and anti-CEA F (ab')2 fragments as potential immunoeontrast agents: relaxometry, biodistribution and magnetic resonance imaging in nude mice grafted with human colorectal carcinoma. Invest Radiol, 1998,33:752-761.
  • 6Kornguth SE, Turski PA, Perman WH, et al. Magnetic resonance imaging of godolinium-labeled monoclonal antibody polymers directed at human T lymphocytes implanted in canine brain. J Neurosurg,1957,66:898-906.
  • 7Cerdan S, Lotscher HR, Kunnecke B, et al. Monoclonal antibodycoated magnetite particles as contrast agents in magnetic resonance imaging of tumors. Mag Reson Med, 1989,12 : 151-163.
  • 8Konda SD, Aref M, Brechbiel M, et al. Development of a tumortargeting MR contrast agent using the high-affinity folate receptor:work in progress. Invest Radiol, 2000,35:50-57.
  • 9Konda SD, Wang S, Brechbiel M, et al. Biodistribution of a 153Gd-folate dendrimer, generation =4, in mice with folate-receptor poSITive and negative ovarian tumor xengrafts. Invest Radiol ,2002,37 : 199-204.
  • 10Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines: physiologic and clinical implications. Cancer,1994, 73:2432-2443.

共引文献61

同被引文献38

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部